Ace inhibitors

Xem 1-17 trên 17 kết quả Ace inhibitors
  • Inhibitors of the RAA System lasting effect than does captopril. Indications are hypertension and cardiac failure. Lowering of an elevated blood pressure is predominantly brought about by diminished production of angiotensin II. Impaired degradation of kinins that exert vasodilating actions may contribute to the effect. In heart failure, cardiac output rises again because ventricular afterload diminishes due to a fall in peripheral resistance.

    pdf14p bigbaby87 04-09-2010 89 11   Download

  • Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học 'Respiratory Research cung cấp cho các bạn kiến thức về ngành y đề tài:" Impact of statins and ACE inhibitors on mortality after COPD exacerbations...

    pdf9p toshiba12 20-10-2011 19 2   Download

  • Nhóm thuốc Thuốc Ghi chú Ức chế men chuyển (ACE inhibitors ) Benazepril Thuốc ức chế men chuyển làm dãn mạch máu do đó giảm sự gắng sức Captopril của tim qua cơ chế ức chế một trong Enalapril dây chuyền hệ thống RAA gây co mạch và giữ nước. Thuốc có hiệu quả làm Fosinopril giảm triệu chứng và nhập viện và kéo Lisinopril dài tuổi thọ ở bệnh nhân suy tim.

    pdf8p doremonmap 08-09-2010 114 43   Download

  • Hypertension and coronary heart disease (CHD) are of great importance. Hypertension affects above 20% of the total population of the USA with its major impact on those over age 50. CHD is the cause of death in 30% of males and 22% of females in England and Wales. Management requires attention to detail, both clinical and pharmacological. The way drugs act in these diseases is outlined and the drugs are described according to class.

    pdf18p bigbaby87 03-09-2010 57 12   Download

  • Cardiovascular disease, including coronary heart disease, strokes and diseases of other arteries, is a major cause of early death and disability. For many years the major markers of disease risk have been well recognised: these include high blood cholesterol levels and smoking. But it has also been recognised that these markers do not account for all cardiovascular risk. Furthermore, treatments that are highly effective in altering these markers, for instance the ‘statin’ drugs used to lower cholesterol, do not remove risk entirely: typically they reduce it by about 30% or less.

    pdf398p cronus75 14-01-2013 40 8   Download

  • Vasodilators alogues such as iloprost, or prostaglandin E1 analogues such as alprostanil, mimic the actions of relaxant mediators. Ca2+ antagonists reduce depolarizing inward Ca2+ currents, while K+-channel activators promote outward (hyperpolarizing) K+ currents. Organic nitrovasodilators give rise to NO, an endogenous activator of guanylate cyclase. Individual vasodilators. Nitrates (p. 120) Ca2+-antagonists (p. 122). "1antagonists (p. 90), ACE-inhibitors, AT1antagonists (p. 124); and sodium nitroprusside (p. 120) are discussed elsewhere.

    pdf6p bigbaby87 04-09-2010 45 7   Download

  • Decreased aldosterone synthesis may be due to primary adrenal insufficiency (Addison's disease) or congenital adrenal enzyme deficiency (Chap. 336). Heparin (including low-molecular-weight heparin) inhibits production of aldosterone by the cells of the zona glomerulosa and can lead to severe hyperkalemia in a subset of patients with underlying renal disease, diabetes mellitus, or those receiving K+-sparing diuretics, ACE inhibitors, or NSAIDs.

    pdf5p ongxaemnumber1 29-11-2010 37 5   Download

  • The purpose of this dictionary is to provide a convenient and affordable personal desk reference resource. The authors, who have many years experience in pharmacological research, teaching and editing, recognized a need for a single up-to-date volume encompassing material that hitherto could be gathered only from a well-stocked library. This book comprises two main sections: an A-Z listing of drugs and their properties; and a descriptive glossary of technical terms.

    pdf0p mnemosyne75 02-02-2013 16 4   Download

  • von der Schulenburg et al. Health Economics Review 2011, 1:18 http://www.healtheconomicsreview.com/content/1/1/18 RESEARCH Open Access The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors Fritz von der Schulenburg1,2, Sotiris Vandoros1 and Panos Kanavos1* Abstract This study provides an overview of policy measures targeting pharmaceutical expenditure in Europe and analyses their impact on originator pharmaceutical prices.

    pdf8p dauphong13 10-02-2012 30 4   Download

  • Somatic angiotensin-converting enzyme (ACE) contains two homologous domains, each bearing a functional active site. Studies on the selectivity of these ACE domains towards either substrates or inhibitors have mostly relied on the use of mutants or isolated domains of ACE.

    pdf10p inspiron33 26-03-2013 15 3   Download

  • The increasing awareness of the importance of chirality in the context of biological activity has stimulated a growing demand for efficient methods for industrial synthesis of pure enantiomers including chiral antiinflammatory drugs such as naproxen (Xin et al., 2001) and ibuprofen (Lee et al., 1995; Ducret et al., 1998; Xie et al., 1998; Arroyo et al., 1999; Chen and Tsai, 2000); antihypertensive agents such as angiotensin-converting enzyme (ACE) inhibitors (e.g., captopril, enalapril, ceranopril, zofenapril, and lisinopril); and the calcium channel- blocking drugs such as diltiazem.

    pdf109p loixinloi 08-05-2013 21 3   Download

  • In stark contrast to the extraordinary lengths to which patients in wealthy countries will go to treat ischemic cardiomyopathy, young patients with nonischemic cardiomyopathies in resource-poor settings have received little attention. These conditions account for as many as 25–30% of admissions for heart failure in sub-Saharan Africa and include poorly understood entities such as peripartum cardiomyopathy (which has an incidence in rural Haiti of 1 per 300 live births) and HIV cardiomyopathy.

    pdf5p tubreakdance 26-11-2010 51 3   Download

  • Angiotensin-converting–enzyme (ACE) inhibitors are effective in reducing the risk of heart failure, myocardial infarction, and death from cardiovascular causes in patients with left ventricular systolic dysfunction or heart failure. ACE inhibitors have also been shown to reduce atherosclerotic complications in patients who have vascular disease without heart failure.

    pdf15p muakhuya 07-07-2012 35 2   Download

  • A protocol to follow the processing of angiotensin I into angiotensin II by rabbit angiotensin-converting enzyme (ACE) and its inhibition by a novel natural antagonist, the leech osmoregulator factor (LORF) using capillary zonal electrophoresis is described. The experiment was carried out using the Beckman PACE system and steps were taken to determine (a) the migration profiles of angiotensin and its yielded peptides, (b) the minimal amount of angiotensin II detected, (c) the use of different electrolytes and (d) the concentration of inhibitor. ...

    pdf6p dell39 03-04-2013 14 2   Download

  • The crystal structure of a Drosophila angiotensin-converting enzyme (ANCE) has recently been solved, revealing features important for the binding of ACE inhibitors and allowing molecular comparisons with the structure of human testicular angiotensin-converting enzyme (tACE). ACER is a secondDrosophilaACE that displays both common and dis-tinctive properties.

    pdf12p dell39 27-03-2013 16 1   Download

  • Angiotensin-converting enzyme-2 (ACE2) may play an important role in cardiorenal disease and it has also been implicated as a cellular receptor for the severe acute respiratory syndrome (SARS) virus. The ACE2 active-site model and its crystal structure, which was solved recently, highlighted key differences between ACE2 and its counterpart angiotensin-converting enzyme (ACE), which are responsible for their differing substrate and inhibitor sensitivities.

    pdf9p fptmusic 11-04-2013 11 1   Download

  • E2020 (R,S)-1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]-methyl)piperidine hydrochloride isa piperidine-based ace-tylcholinesterase (AChE) inhibitor that was approved for the treatment of Alzheimer’s disease in the United States. Structure-activity studiesof thisclassof inhibitorshave indicated that both the benzoyl containing functionality and the N-benzylpiperidine moiety are the key featuresfor binding and inhibition of AChE.

    pdf12p fptmusic 12-04-2013 10 1   Download

CHỦ ĐỀ BẠN MUỐN TÌM

Đồng bộ tài khoản